Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib

alexandrossfakianakis shared this article with you from Inoreader Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib via ScienceDirect Publication: Experimental Cell Research Publication date: Available online 26 May 2022 Source: Experimental Cell Research Author(s): Chih-Wei Chen, Nai-Kuei Huang, Yueh-Lun Lee, Chia-Kwung Fan, Yen-Chou Chen, Chin-Wei Liu, Huei-Mei Huang View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.